Jeffrey Sevigny

Insider Reports History

Location
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Sevigny:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 300K Apr 1, 2025 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 15, 2022 Direct

Insider Reports Filed by Jeffrey Sevigny

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Apr 1, 2025 1 $0 4 Apr 3, 2025 Chief Medical Officer
RAPP Rapport Therapeutics, Inc. Mar 3, 2025 0 $0 3 Mar 5, 2025 Chief Medical Officer
ABOS Acumen Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 Director